WC
Woodstock Corp Portfolio holdings
AUM
$1.09B
This Quarter Return
+5.57%
1 Year Return
+20.65%
3 Year Return
+97.37%
5 Year Return
+175.97%
10 Year Return
+415.12%
AUM
$542M
AUM Growth
+$542M
(+3.4%)
Cap. Flow
+$6.87M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
25.23%
Holding
170
New
9
Increased
45
Reduced
68
Closed
4
Top Buys
| 1 |
Fortinet
FTNT
|
$873K |
| 2 |
Commerce Bancshares
CBSH
|
$438K |
| 3 |
Walt Disney
DIS
|
$437K |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$428K |
| 5 |
AQ
Aquantia Corp. Common Stock
AQ
|
$346K |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$2.44M |
| 2 |
F5
FFIV
|
$1.04M |
| 3 |
GE Aerospace
GE
|
$704K |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$541K |
| 5 |
Biogen
BIIB
|
$513K |
Sector Composition
| 1 | Healthcare | 23.89% |
| 2 | Technology | 17.7% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Staples | 9.27% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kinder Morgan
KMI
$59.4B
| $753K | 0.14% |
41,663
-23,975
| -37% | -$433K |
|
102
Leggett & Platt
LEG
$1.28B
| $745K | 0.14% |
15,600
| – | – |
|
103
Novartis
NVS
$248B
| $718K | 0.13% |
8,552
| – | – |
|
104
Akamai
AKAM
$11.1B
| $696K | 0.13% |
10,708
+1,550
| +17% | +$101K |
|
|
GWPH
105
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $694K | 0.13% |
5,256
| – | – |
|
106
Alibaba
BABA
$325B
| $679K | 0.13% |
3,936
| – | – |
|
107
Vertex Pharmaceuticals
VRTX
$102B
| $647K | 0.12% |
4,319
| – | – |
|
108
T Rowe Price
TROW
$23.2B
| $632K | 0.12% |
6,021
-450
| -7% | -$47.2K |
|
109
Omnicom Group
OMC
$15B
| $609K | 0.11% |
8,360
| – | – |
|
110
Hershey
HSY
$37.4B
| $603K | 0.11% |
5,308
-350
| -6% | -$39.8K |
|
111
Lowe's Companies
LOW
$146B
| $594K | 0.11% |
6,395
| – | – |
|
|
NBL
112
DELISTED
Noble Energy, Inc.
NBL
| $589K | 0.11% |
20,212
+16
| +0.1% | +$466 |
|
113
APA Corp
APA
$8.11B
| $563K | 0.1% |
13,337
-1,525
| -10% | -$64.4K |
|
114
DuPont de Nemours
DD
$31.6B
| $512K | 0.09% |
7,188
+577
| +9% | +$41.1K |
|
115
Corbus Pharmaceuticals
CRBP
$121M
| $511K | 0.09% |
72,001
| – | – |
|
|
CAVM
116
DELISTED
Cavium, Inc.
CAVM
| $484K | 0.09% |
5,773
| – | – |
|
117
Emergent Biosolutions
EBS
$418M
| $482K | 0.09% |
10,369
-2,643
| -20% | -$123K |
|
118
Patterson-UTI
PTEN
$2.13B
| $454K | 0.08% |
19,735
| – | – |
|
119
Danaher
DHR
$143B
| $448K | 0.08% |
4,830
+980
| +25% | +$90.9K |
|
120
Honeywell
HON
$136B
| $442K | 0.08% |
2,885
| – | – |
|
|
121
Commerce Bancshares
CBSH
$8.18B
| $438K | 0.08% |
+7,840
| New | +$438K |
|
|
RETA
122
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $428K | 0.08% |
+15,116
| New | +$428K |
|
123
Eli Lilly
LLY
$661B
| $405K | 0.07% |
4,800
| – | – |
|
124
Vanguard Total Stock Market ETF
VTI
$524B
| $402K | 0.07% |
2,930
-200
| -6% | -$27.4K |
|
|
EPZM
125
DELISTED
Epizyme, Inc
EPZM
| $399K | 0.07% |
31,766
| – | – |
|